Skip to main content
Fate Therapeutics, Inc. (FATE)
NASDAQ: FATE · Real-Time Price · USD
1.300
-0.010 (-0.76%)
At close: Apr 28, 2026, 4:00 PM EDT
1.340
+0.040 (3.08%)
After-hours: Apr 28, 2026, 4:59 PM EDT

Fate Therapeutics Employees

Fate Therapeutics had 161 employees as of December 31, 2025. The number of employees decreased by 20 or -11.05% compared to the previous year.

Employees
161
Change (1Y)
-20
Growth (1Y)
-11.05%
Revenue / Employee
$41,280
Profits / Employee
-$846,677
Market Cap
151.14M

Employees Chart

Employees History

Date Employees Change Growth
Dec 31, 2025161-20-11.05%
Dec 31, 20241810-
Dec 31, 2023181-370-67.15%
Dec 31, 202255110222.72%
Dec 31, 202144917060.93%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Related Stocks

Company Name Employees
Humacyte 184
Molecular Partners AG 134
Alps Group 93
Agenus 81
Spero Therapeutics 25
TuHURA Biosciences 22
AN2 Therapeutics 21
Galectin Therapeutics 9
Employee Rankings

FATE News

More News